GlassScriptPhysician profile
Emily Towery
NPI 1164017612
$383.36
in general payments reported to CMS, 2019-2025
13 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.21 · 2024: $33.91 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $93.09 | 2025 | Bimzelx |
| Amgen INC. | $36.86 | 2025 | Enbrel, Otezla, Evenity |
| Genzyme Corporation | $33.94 | 2025 | |
| Sobi, INC | $30.31 | 2025 | |
| Novartis Pharmaceuticals Corporation | $29.58 | 2025 | |
| Abbvie INC. | $27.20 | 2025 | |
| Tersera Therapeutics LLC | $24.52 | 2025 | Quzyttir |
| Medtronic, INC. | $21.34 | 2025 | Synchromedii |
| Melinta Therapeutics, LLC | $20.41 | 2025 | Kimyrsa, Rezzayo |
| Scilex Pharmaceuticals INC. | $19.91 | 2024 | |
| Kyowa Kirin, INC. | $17.99 | 2025 | |
| Enterra Medical, INC. | $14.21 | 2022 | |
| Spinal Simplicity, LLC | $14.00 | 2024 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Towery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.